MedPath

DOLOMENSIN

DOLOMENSIN

Discontinued
DIN Number

00245496

Drug Class

Human

Market Date

Dec 31, 1972

Company
HC

dr reckeweg and co

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00245496
AIG Number0601818001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

CAULOPHYLLUM THALICTROIDESActive
Strength: 2 X / X
Monograph: CAULOPHYLLUM THALICTROIDES
CHAMOMILEActive
Strength: 30 X / X
Monograph: CHAMOMILE
CIMICIFUGA RACEMOSAActive
Strength: 3 X / X
Monograph: CIMICIFUGA RACEMOSA
CUPRIC ACETATEActive
Strength: 4 X / X
Monograph: CUPRIC ACETATE
MAGNESIUM PHOSPHATE DIBASICActive
Strength: 6 X / X
Monograph: MAGNESIUM PHOSPHATE DIBASIC
VIBURNUM OPULUSActive
Strength: 2 X / X
Monograph: VIBURNUM OPULUS

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.